PerkinElmer Inc (PKI) Key Developments | Reuters.com
Edition:
United States

PerkinElmer Inc (PKI)

PKI on New York Consolidated

51.62USD
29 Jun 2016
Change (% chg)

-- (--)
Prev Close
$51.62
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
719,314
52-wk High
$56.12
52-wk Low
$39.50

Latest Key Developments (Source: Significant Developments)

PerkinElmer Inc declares quarterly dividend
Thursday, 28 Jan 2016 05:33pm EST 

PerkinElmer Inc:Declared a regular quarterly dividend of $0.07 per share of common stock.Payable on May 10 to all shareholders of record date as on April 15.  Full Article

PerkinElmer acquires Vanadis Diagnostics, AB
Tuesday, 26 Jan 2016 08:00am EST 

PerkinElmer Inc:Announced that it has completed the acquisition of Vanadis Diagnostics, AB.  Full Article

PerkinElmer declares quarterly dividend
Thursday, 29 Oct 2015 04:05pm EDT 

PerkinElmer Inc:Declares a regular quarterly dividend of $0.07 per share of common stock on October 29, 2015.Payable on Feb. 10 to all shareholders of record at the close of business on Jan. 15.  Full Article

PerkinElmer Inc raises low end of prior FY 2015 EPS guidance to a range in line with analysts' estimates
Thursday, 30 Jul 2015 04:18pm EDT 

PerkinElmer Inc:Forecasts FY 2015 GAAP earnings per share from continuing operations in range of $2.00 to $2.05.Forecasts FY 2015, on a non-GAAP basis adjusted earnings per share in the range of $2.55 to $2.60.FY 2015 EPS of $2.59 - Thomson Reuters I/B/E/S.  Full Article

PerkinElmer declares quarterly dividend
Thursday, 23 Jul 2015 04:05pm EDT 

PerkinElmer:Declared a regular quarterly dividend of $0.07 per share of common stock on July 22, 2015.Says this dividend is payable on November 10, 2015 to all shareholders of record at the close of business on October 16, 2015.  Full Article

Albany Molecular Research Inc and PerkinElmer Inc announce drug discovery collaboration
Wednesday, 17 Jun 2015 07:00am EDT 

Albany Molecular Research Inc and PerkinElmer Inc:Says formation of strategic collaboration in connection with opening of AMRI's drug discovery center as part of new Buffalo Medical Innovation and Commercialization Hub (BMIC).Co-located on Buffalo Niagara Medical Campus and part of the larger commitment by the State of New York with SUNY Polytechnic Institute, Hub will accelerate drug discovery and innovation, and ultimately support creation of more than 250 high tech jobs.  Full Article

PerkinElmer Inc lowers FY 2015 EPS guidance
Thursday, 30 Apr 2015 04:05pm EDT 

PerkinElmer Inc:Forecasts FY 2015 GAAP earnings per share from continuing operations in the range of $2.06 to $2.12.Updates FY 2015 on non-GAAP basis, which is expected to include the adjustments noted in the attached reconciliation, adjusted earnings per share of $2.54 to $2.60 which now represents 12-15pct constant currency adjusted earnings per share growth as compared to prior guidance of 11-13pct.FY 2015 EPS of $2.60 - Thomson Reuters I/B/E/S.  Full Article

PerkinElmer Inc declares quarterly dividend
Monday, 27 Apr 2015 04:27pm EDT 

PerkinElmer Inc:Declares regular quarterly dividend of $0.07 per share of common stock on April 27.Payable on Aug. 10, to all shareholders of record at close of business on July 17.  Full Article

PerkinElmer Inc gives FY 2015 EPS guidance in line with analysts' estimates
Thursday, 29 Jan 2015 04:05pm EST 

PerkinElmer Inc:Forecasts FY 2015 GAAP earnings per share from continuing operations in the range of $2.04 to $2.10 and on a non-GAAP basis, which is expected to include adjustments noted in attached reconciliation, adjusted earnings per share (EPS) of $2.58 to $2.64.FY 2015 EPS of $2.64 - Thomson Reuters I/B/E/S.  Full Article

PerkinElmer declares quarterly dividend
Friday, 23 Jan 2015 04:13pm EST 

PerkinElmer Inc:Declares a regular quarterly dividend of $0.07 per share of common stock on Jan. 23.Payable on May 11 to all shareholders of record at the close of business on April 17.  Full Article

BRIEF-PerkinElmer Q1 GAAP shr from cont ops $0.43

* Perkinelmer q1 adjusted operating profit margin 16.7 percent as percentage of adjusted revenue versus 15.7 percent last year